nodes	percent_of_prediction	percent_of_DWPC	metapath
Pilocarpine—CYP2A6—lung cancer	0.351	0.585	CbGaD
Pilocarpine—CYP2E1—lung cancer	0.249	0.415	CbGaD
Pilocarpine—CYP2E1—Etoposide—lung cancer	0.0238	0.155	CbGbCtD
Pilocarpine—CYP3A4—Topotecan—lung cancer	0.0184	0.12	CbGbCtD
Pilocarpine—CYP3A4—Gefitinib—lung cancer	0.0168	0.11	CbGbCtD
Pilocarpine—CYP3A4—Teniposide—lung cancer	0.0163	0.106	CbGbCtD
Pilocarpine—CYP3A4—Vinorelbine—lung cancer	0.013	0.0846	CbGbCtD
Pilocarpine—CYP3A4—Crizotinib—lung cancer	0.0103	0.0673	CbGbCtD
Pilocarpine—CYP3A4—Erlotinib—lung cancer	0.00996	0.0649	CbGbCtD
Pilocarpine—CYP3A4—Paclitaxel—lung cancer	0.00912	0.0594	CbGbCtD
Pilocarpine—CYP3A4—Irinotecan—lung cancer	0.00899	0.0586	CbGbCtD
Pilocarpine—CYP3A4—Vinblastine—lung cancer	0.008	0.0521	CbGbCtD
Pilocarpine—CYP3A4—Etoposide—lung cancer	0.0072	0.047	CbGbCtD
Pilocarpine—CYP3A4—Docetaxel—lung cancer	0.00659	0.043	CbGbCtD
Pilocarpine—CYP3A4—Doxorubicin—lung cancer	0.00491	0.032	CbGbCtD
Pilocarpine—Vomiting—Vinorelbine—lung cancer	9.43e-05	0.000522	CcSEcCtD
Pilocarpine—Body temperature increased—Gemcitabine—lung cancer	9.42e-05	0.000522	CcSEcCtD
Pilocarpine—Rash—Vinorelbine—lung cancer	9.35e-05	0.000518	CcSEcCtD
Pilocarpine—Dermatitis—Vinorelbine—lung cancer	9.34e-05	0.000517	CcSEcCtD
Pilocarpine—Hypotension—Paclitaxel—lung cancer	9.32e-05	0.000516	CcSEcCtD
Pilocarpine—Stomatitis—Methotrexate—lung cancer	9.31e-05	0.000516	CcSEcCtD
Pilocarpine—Headache—Vinorelbine—lung cancer	9.29e-05	0.000515	CcSEcCtD
Pilocarpine—Syncope—Docetaxel—lung cancer	9.29e-05	0.000515	CcSEcCtD
Pilocarpine—Conjunctivitis—Methotrexate—lung cancer	9.29e-05	0.000514	CcSEcCtD
Pilocarpine—Influenza—Doxorubicin—lung cancer	9.28e-05	0.000514	CcSEcCtD
Pilocarpine—Dysphagia—Doxorubicin—lung cancer	9.28e-05	0.000514	CcSEcCtD
Pilocarpine—Leukopenia—Docetaxel—lung cancer	9.27e-05	0.000514	CcSEcCtD
Pilocarpine—Sweating—Methotrexate—lung cancer	9.16e-05	0.000507	CcSEcCtD
Pilocarpine—Palpitations—Docetaxel—lung cancer	9.16e-05	0.000507	CcSEcCtD
Pilocarpine—Feeling abnormal—Cisplatin—lung cancer	9.15e-05	0.000507	CcSEcCtD
Pilocarpine—Paraesthesia—Etoposide—lung cancer	9.14e-05	0.000506	CcSEcCtD
Pilocarpine—Haematuria—Methotrexate—lung cancer	9.11e-05	0.000505	CcSEcCtD
Pilocarpine—Loss of consciousness—Docetaxel—lung cancer	9.11e-05	0.000504	CcSEcCtD
Pilocarpine—Pancreatitis—Doxorubicin—lung cancer	9.1e-05	0.000504	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Paclitaxel—lung cancer	9.09e-05	0.000503	CcSEcCtD
Pilocarpine—Dyspnoea—Etoposide—lung cancer	9.07e-05	0.000502	CcSEcCtD
Pilocarpine—Somnolence—Etoposide—lung cancer	9.05e-05	0.000501	CcSEcCtD
Pilocarpine—Cough—Docetaxel—lung cancer	9.04e-05	0.000501	CcSEcCtD
Pilocarpine—Angina pectoris—Doxorubicin—lung cancer	9.04e-05	0.000501	CcSEcCtD
Pilocarpine—Insomnia—Paclitaxel—lung cancer	9.02e-05	0.0005	CcSEcCtD
Pilocarpine—Epistaxis—Methotrexate—lung cancer	9.01e-05	0.000499	CcSEcCtD
Pilocarpine—Hypersensitivity—Irinotecan—lung cancer	9.01e-05	0.000499	CcSEcCtD
Pilocarpine—Paraesthesia—Paclitaxel—lung cancer	8.96e-05	0.000496	CcSEcCtD
Pilocarpine—Hypertension—Docetaxel—lung cancer	8.95e-05	0.000495	CcSEcCtD
Pilocarpine—Bronchitis—Doxorubicin—lung cancer	8.93e-05	0.000494	CcSEcCtD
Pilocarpine—Dyspnoea—Paclitaxel—lung cancer	8.89e-05	0.000493	CcSEcCtD
Pilocarpine—Somnolence—Paclitaxel—lung cancer	8.87e-05	0.000491	CcSEcCtD
Pilocarpine—Decreased appetite—Etoposide—lung cancer	8.85e-05	0.00049	CcSEcCtD
Pilocarpine—Chest pain—Docetaxel—lung cancer	8.82e-05	0.000488	CcSEcCtD
Pilocarpine—Myalgia—Docetaxel—lung cancer	8.82e-05	0.000488	CcSEcCtD
Pilocarpine—Arthralgia—Docetaxel—lung cancer	8.82e-05	0.000488	CcSEcCtD
Pilocarpine—Nausea—Vinorelbine—lung cancer	8.81e-05	0.000488	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Etoposide—lung cancer	8.78e-05	0.000486	CcSEcCtD
Pilocarpine—Dyspepsia—Paclitaxel—lung cancer	8.78e-05	0.000486	CcSEcCtD
Pilocarpine—Body temperature increased—Cisplatin—lung cancer	8.78e-05	0.000486	CcSEcCtD
Pilocarpine—Asthenia—Irinotecan—lung cancer	8.78e-05	0.000486	CcSEcCtD
Pilocarpine—Pain—Etoposide—lung cancer	8.7e-05	0.000482	CcSEcCtD
Pilocarpine—Constipation—Etoposide—lung cancer	8.7e-05	0.000482	CcSEcCtD
Pilocarpine—Dysuria—Doxorubicin—lung cancer	8.68e-05	0.000481	CcSEcCtD
Pilocarpine—Decreased appetite—Paclitaxel—lung cancer	8.67e-05	0.00048	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Paclitaxel—lung cancer	8.61e-05	0.000477	CcSEcCtD
Pilocarpine—Hepatitis—Methotrexate—lung cancer	8.58e-05	0.000475	CcSEcCtD
Pilocarpine—Pollakiuria—Doxorubicin—lung cancer	8.57e-05	0.000475	CcSEcCtD
Pilocarpine—Asthenia—Gemcitabine—lung cancer	8.55e-05	0.000473	CcSEcCtD
Pilocarpine—Pain—Paclitaxel—lung cancer	8.53e-05	0.000472	CcSEcCtD
Pilocarpine—Constipation—Paclitaxel—lung cancer	8.53e-05	0.000472	CcSEcCtD
Pilocarpine—Confusional state—Docetaxel—lung cancer	8.53e-05	0.000472	CcSEcCtD
Pilocarpine—Pharyngitis—Methotrexate—lung cancer	8.51e-05	0.000471	CcSEcCtD
Pilocarpine—Photosensitivity reaction—Doxorubicin—lung cancer	8.47e-05	0.000469	CcSEcCtD
Pilocarpine—Oedema—Docetaxel—lung cancer	8.46e-05	0.000468	CcSEcCtD
Pilocarpine—Pruritus—Gemcitabine—lung cancer	8.43e-05	0.000467	CcSEcCtD
Pilocarpine—Infection—Docetaxel—lung cancer	8.4e-05	0.000465	CcSEcCtD
Pilocarpine—Feeling abnormal—Etoposide—lung cancer	8.38e-05	0.000464	CcSEcCtD
Pilocarpine—Diarrhoea—Irinotecan—lung cancer	8.37e-05	0.000463	CcSEcCtD
Pilocarpine—Pneumonia—Doxorubicin—lung cancer	8.32e-05	0.000461	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Etoposide—lung cancer	8.32e-05	0.000461	CcSEcCtD
Pilocarpine—Shock—Docetaxel—lung cancer	8.32e-05	0.000461	CcSEcCtD
Pilocarpine—Thrombocytopenia—Docetaxel—lung cancer	8.28e-05	0.000458	CcSEcCtD
Pilocarpine—Visual impairment—Methotrexate—lung cancer	8.27e-05	0.000458	CcSEcCtD
Pilocarpine—Tachycardia—Docetaxel—lung cancer	8.25e-05	0.000457	CcSEcCtD
Pilocarpine—Feeling abnormal—Paclitaxel—lung cancer	8.22e-05	0.000455	CcSEcCtD
Pilocarpine—Hypersensitivity—Cisplatin—lung cancer	8.18e-05	0.000453	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Paclitaxel—lung cancer	8.16e-05	0.000452	CcSEcCtD
Pilocarpine—Diarrhoea—Gemcitabine—lung cancer	8.15e-05	0.000451	CcSEcCtD
Pilocarpine—Dizziness—Irinotecan—lung cancer	8.09e-05	0.000448	CcSEcCtD
Pilocarpine—Stomatitis—Doxorubicin—lung cancer	8.07e-05	0.000447	CcSEcCtD
Pilocarpine—Anorexia—Docetaxel—lung cancer	8.06e-05	0.000446	CcSEcCtD
Pilocarpine—Abdominal pain—Etoposide—lung cancer	8.04e-05	0.000445	CcSEcCtD
Pilocarpine—Body temperature increased—Etoposide—lung cancer	8.04e-05	0.000445	CcSEcCtD
Pilocarpine—Conjunctivitis—Doxorubicin—lung cancer	8.04e-05	0.000445	CcSEcCtD
Pilocarpine—Urinary tract infection—Doxorubicin—lung cancer	8.04e-05	0.000445	CcSEcCtD
Pilocarpine—Eye disorder—Methotrexate—lung cancer	8.02e-05	0.000444	CcSEcCtD
Pilocarpine—Tinnitus—Methotrexate—lung cancer	8e-05	0.000443	CcSEcCtD
Pilocarpine—Asthenia—Cisplatin—lung cancer	7.97e-05	0.000441	CcSEcCtD
Pilocarpine—Sweating—Doxorubicin—lung cancer	7.93e-05	0.000439	CcSEcCtD
Pilocarpine—Hypotension—Docetaxel—lung cancer	7.9e-05	0.000438	CcSEcCtD
Pilocarpine—Haematuria—Doxorubicin—lung cancer	7.89e-05	0.000437	CcSEcCtD
Pilocarpine—Abdominal pain—Paclitaxel—lung cancer	7.89e-05	0.000437	CcSEcCtD
Pilocarpine—Body temperature increased—Paclitaxel—lung cancer	7.89e-05	0.000437	CcSEcCtD
Pilocarpine—Epistaxis—Doxorubicin—lung cancer	7.8e-05	0.000432	CcSEcCtD
Pilocarpine—Vomiting—Irinotecan—lung cancer	7.78e-05	0.000431	CcSEcCtD
Pilocarpine—Sinusitis—Doxorubicin—lung cancer	7.76e-05	0.00043	CcSEcCtD
Pilocarpine—Rash—Irinotecan—lung cancer	7.71e-05	0.000427	CcSEcCtD
Pilocarpine—Dermatitis—Irinotecan—lung cancer	7.71e-05	0.000427	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Docetaxel—lung cancer	7.7e-05	0.000427	CcSEcCtD
Pilocarpine—Chills—Methotrexate—lung cancer	7.7e-05	0.000426	CcSEcCtD
Pilocarpine—Headache—Irinotecan—lung cancer	7.66e-05	0.000424	CcSEcCtD
Pilocarpine—Insomnia—Docetaxel—lung cancer	7.65e-05	0.000423	CcSEcCtD
Pilocarpine—Diarrhoea—Cisplatin—lung cancer	7.6e-05	0.000421	CcSEcCtD
Pilocarpine—Paraesthesia—Docetaxel—lung cancer	7.59e-05	0.00042	CcSEcCtD
Pilocarpine—Alopecia—Methotrexate—lung cancer	7.58e-05	0.00042	CcSEcCtD
Pilocarpine—Vomiting—Gemcitabine—lung cancer	7.58e-05	0.00042	CcSEcCtD
Pilocarpine—Bradycardia—Doxorubicin—lung cancer	7.56e-05	0.000419	CcSEcCtD
Pilocarpine—Dyspnoea—Docetaxel—lung cancer	7.54e-05	0.000417	CcSEcCtD
Pilocarpine—Somnolence—Docetaxel—lung cancer	7.52e-05	0.000416	CcSEcCtD
Pilocarpine—Rash—Gemcitabine—lung cancer	7.51e-05	0.000416	CcSEcCtD
Pilocarpine—Dermatitis—Gemcitabine—lung cancer	7.51e-05	0.000416	CcSEcCtD
Pilocarpine—Hypersensitivity—Etoposide—lung cancer	7.5e-05	0.000415	CcSEcCtD
Pilocarpine—Headache—Gemcitabine—lung cancer	7.46e-05	0.000413	CcSEcCtD
Pilocarpine—Rhinitis—Doxorubicin—lung cancer	7.45e-05	0.000412	CcSEcCtD
Pilocarpine—Dyspepsia—Docetaxel—lung cancer	7.44e-05	0.000412	CcSEcCtD
Pilocarpine—Hepatitis—Doxorubicin—lung cancer	7.43e-05	0.000411	CcSEcCtD
Pilocarpine—Hypoaesthesia—Doxorubicin—lung cancer	7.39e-05	0.000409	CcSEcCtD
Pilocarpine—Pharyngitis—Doxorubicin—lung cancer	7.37e-05	0.000408	CcSEcCtD
Pilocarpine—Decreased appetite—Docetaxel—lung cancer	7.35e-05	0.000407	CcSEcCtD
Pilocarpine—Hypersensitivity—Paclitaxel—lung cancer	7.35e-05	0.000407	CcSEcCtD
Pilocarpine—Oedema peripheral—Doxorubicin—lung cancer	7.32e-05	0.000405	CcSEcCtD
Pilocarpine—Dysgeusia—Methotrexate—lung cancer	7.31e-05	0.000405	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Docetaxel—lung cancer	7.3e-05	0.000404	CcSEcCtD
Pilocarpine—Asthenia—Etoposide—lung cancer	7.3e-05	0.000404	CcSEcCtD
Pilocarpine—Nausea—Irinotecan—lung cancer	7.27e-05	0.000402	CcSEcCtD
Pilocarpine—Pain—Docetaxel—lung cancer	7.23e-05	0.0004	CcSEcCtD
Pilocarpine—Constipation—Docetaxel—lung cancer	7.23e-05	0.0004	CcSEcCtD
Pilocarpine—Back pain—Methotrexate—lung cancer	7.22e-05	0.0004	CcSEcCtD
Pilocarpine—Pruritus—Etoposide—lung cancer	7.2e-05	0.000399	CcSEcCtD
Pilocarpine—Visual impairment—Doxorubicin—lung cancer	7.16e-05	0.000396	CcSEcCtD
Pilocarpine—Asthenia—Paclitaxel—lung cancer	7.16e-05	0.000396	CcSEcCtD
Pilocarpine—Nausea—Gemcitabine—lung cancer	7.08e-05	0.000392	CcSEcCtD
Pilocarpine—Vomiting—Cisplatin—lung cancer	7.06e-05	0.000391	CcSEcCtD
Pilocarpine—Pruritus—Paclitaxel—lung cancer	7.06e-05	0.000391	CcSEcCtD
Pilocarpine—Vision blurred—Methotrexate—lung cancer	7.04e-05	0.00039	CcSEcCtD
Pilocarpine—Rash—Cisplatin—lung cancer	7e-05	0.000388	CcSEcCtD
Pilocarpine—Dermatitis—Cisplatin—lung cancer	7e-05	0.000387	CcSEcCtD
Pilocarpine—Feeling abnormal—Docetaxel—lung cancer	6.97e-05	0.000386	CcSEcCtD
Pilocarpine—Diarrhoea—Etoposide—lung cancer	6.96e-05	0.000385	CcSEcCtD
Pilocarpine—Eye disorder—Doxorubicin—lung cancer	6.94e-05	0.000384	CcSEcCtD
Pilocarpine—Tinnitus—Doxorubicin—lung cancer	6.93e-05	0.000383	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Docetaxel—lung cancer	6.91e-05	0.000383	CcSEcCtD
Pilocarpine—Flushing—Doxorubicin—lung cancer	6.89e-05	0.000382	CcSEcCtD
Pilocarpine—Diarrhoea—Paclitaxel—lung cancer	6.83e-05	0.000378	CcSEcCtD
Pilocarpine—Dizziness—Etoposide—lung cancer	6.73e-05	0.000373	CcSEcCtD
Pilocarpine—Abdominal pain—Docetaxel—lung cancer	6.68e-05	0.00037	CcSEcCtD
Pilocarpine—Body temperature increased—Docetaxel—lung cancer	6.68e-05	0.00037	CcSEcCtD
Pilocarpine—Leukopenia—Methotrexate—lung cancer	6.68e-05	0.00037	CcSEcCtD
Pilocarpine—Chills—Doxorubicin—lung cancer	6.67e-05	0.000369	CcSEcCtD
Pilocarpine—Arrhythmia—Doxorubicin—lung cancer	6.64e-05	0.000367	CcSEcCtD
Pilocarpine—Dizziness—Paclitaxel—lung cancer	6.6e-05	0.000365	CcSEcCtD
Pilocarpine—Nausea—Cisplatin—lung cancer	6.6e-05	0.000365	CcSEcCtD
Pilocarpine—Alopecia—Doxorubicin—lung cancer	6.56e-05	0.000363	CcSEcCtD
Pilocarpine—Cough—Methotrexate—lung cancer	6.52e-05	0.000361	CcSEcCtD
Pilocarpine—Vomiting—Etoposide—lung cancer	6.47e-05	0.000358	CcSEcCtD
Pilocarpine—Rash—Etoposide—lung cancer	6.42e-05	0.000355	CcSEcCtD
Pilocarpine—Dermatitis—Etoposide—lung cancer	6.41e-05	0.000355	CcSEcCtD
Pilocarpine—Headache—Etoposide—lung cancer	6.37e-05	0.000353	CcSEcCtD
Pilocarpine—Flatulence—Doxorubicin—lung cancer	6.37e-05	0.000353	CcSEcCtD
Pilocarpine—Chest pain—Methotrexate—lung cancer	6.36e-05	0.000352	CcSEcCtD
Pilocarpine—Arthralgia—Methotrexate—lung cancer	6.36e-05	0.000352	CcSEcCtD
Pilocarpine—Myalgia—Methotrexate—lung cancer	6.36e-05	0.000352	CcSEcCtD
Pilocarpine—Tension—Doxorubicin—lung cancer	6.35e-05	0.000351	CcSEcCtD
Pilocarpine—Vomiting—Paclitaxel—lung cancer	6.34e-05	0.000351	CcSEcCtD
Pilocarpine—Dysgeusia—Doxorubicin—lung cancer	6.33e-05	0.000351	CcSEcCtD
Pilocarpine—Rash—Paclitaxel—lung cancer	6.29e-05	0.000348	CcSEcCtD
Pilocarpine—Dermatitis—Paclitaxel—lung cancer	6.28e-05	0.000348	CcSEcCtD
Pilocarpine—Discomfort—Methotrexate—lung cancer	6.28e-05	0.000348	CcSEcCtD
Pilocarpine—Nervousness—Doxorubicin—lung cancer	6.28e-05	0.000348	CcSEcCtD
Pilocarpine—Back pain—Doxorubicin—lung cancer	6.25e-05	0.000346	CcSEcCtD
Pilocarpine—Headache—Paclitaxel—lung cancer	6.25e-05	0.000346	CcSEcCtD
Pilocarpine—Hypersensitivity—Docetaxel—lung cancer	6.23e-05	0.000345	CcSEcCtD
Pilocarpine—Muscle spasms—Doxorubicin—lung cancer	6.22e-05	0.000344	CcSEcCtD
Pilocarpine—Confusional state—Methotrexate—lung cancer	6.15e-05	0.00034	CcSEcCtD
Pilocarpine—Vision blurred—Doxorubicin—lung cancer	6.09e-05	0.000337	CcSEcCtD
Pilocarpine—Asthenia—Docetaxel—lung cancer	6.07e-05	0.000336	CcSEcCtD
Pilocarpine—Infection—Methotrexate—lung cancer	6.05e-05	0.000335	CcSEcCtD
Pilocarpine—Nausea—Etoposide—lung cancer	6.04e-05	0.000335	CcSEcCtD
Pilocarpine—Pruritus—Docetaxel—lung cancer	5.98e-05	0.000331	CcSEcCtD
Pilocarpine—Thrombocytopenia—Methotrexate—lung cancer	5.97e-05	0.00033	CcSEcCtD
Pilocarpine—Agitation—Doxorubicin—lung cancer	5.94e-05	0.000329	CcSEcCtD
Pilocarpine—Nausea—Paclitaxel—lung cancer	5.93e-05	0.000328	CcSEcCtD
Pilocarpine—Hyperhidrosis—Methotrexate—lung cancer	5.89e-05	0.000326	CcSEcCtD
Pilocarpine—Anorexia—Methotrexate—lung cancer	5.81e-05	0.000322	CcSEcCtD
Pilocarpine—Syncope—Doxorubicin—lung cancer	5.8e-05	0.000321	CcSEcCtD
Pilocarpine—Leukopenia—Doxorubicin—lung cancer	5.79e-05	0.000321	CcSEcCtD
Pilocarpine—Diarrhoea—Docetaxel—lung cancer	5.79e-05	0.00032	CcSEcCtD
Pilocarpine—Palpitations—Doxorubicin—lung cancer	5.71e-05	0.000316	CcSEcCtD
Pilocarpine—Hypotension—Methotrexate—lung cancer	5.7e-05	0.000315	CcSEcCtD
Pilocarpine—Loss of consciousness—Doxorubicin—lung cancer	5.68e-05	0.000315	CcSEcCtD
Pilocarpine—Cough—Doxorubicin—lung cancer	5.64e-05	0.000312	CcSEcCtD
Pilocarpine—Dizziness—Docetaxel—lung cancer	5.59e-05	0.00031	CcSEcCtD
Pilocarpine—Hypertension—Doxorubicin—lung cancer	5.58e-05	0.000309	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Methotrexate—lung cancer	5.55e-05	0.000307	CcSEcCtD
Pilocarpine—Insomnia—Methotrexate—lung cancer	5.51e-05	0.000305	CcSEcCtD
Pilocarpine—Chest pain—Doxorubicin—lung cancer	5.51e-05	0.000305	CcSEcCtD
Pilocarpine—Myalgia—Doxorubicin—lung cancer	5.51e-05	0.000305	CcSEcCtD
Pilocarpine—Arthralgia—Doxorubicin—lung cancer	5.51e-05	0.000305	CcSEcCtD
Pilocarpine—Anxiety—Doxorubicin—lung cancer	5.49e-05	0.000304	CcSEcCtD
Pilocarpine—Paraesthesia—Methotrexate—lung cancer	5.47e-05	0.000303	CcSEcCtD
Pilocarpine—Discomfort—Doxorubicin—lung cancer	5.44e-05	0.000301	CcSEcCtD
Pilocarpine—Dyspnoea—Methotrexate—lung cancer	5.43e-05	0.000301	CcSEcCtD
Pilocarpine—Somnolence—Methotrexate—lung cancer	5.42e-05	0.0003	CcSEcCtD
Pilocarpine—Vomiting—Docetaxel—lung cancer	5.38e-05	0.000298	CcSEcCtD
Pilocarpine—Dyspepsia—Methotrexate—lung cancer	5.36e-05	0.000297	CcSEcCtD
Pilocarpine—Rash—Docetaxel—lung cancer	5.33e-05	0.000295	CcSEcCtD
Pilocarpine—Dermatitis—Docetaxel—lung cancer	5.33e-05	0.000295	CcSEcCtD
Pilocarpine—Confusional state—Doxorubicin—lung cancer	5.32e-05	0.000295	CcSEcCtD
Pilocarpine—Decreased appetite—Methotrexate—lung cancer	5.3e-05	0.000293	CcSEcCtD
Pilocarpine—Headache—Docetaxel—lung cancer	5.3e-05	0.000293	CcSEcCtD
Pilocarpine—Oedema—Doxorubicin—lung cancer	5.28e-05	0.000292	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Methotrexate—lung cancer	5.26e-05	0.000291	CcSEcCtD
Pilocarpine—Infection—Doxorubicin—lung cancer	5.24e-05	0.00029	CcSEcCtD
Pilocarpine—Pain—Methotrexate—lung cancer	5.21e-05	0.000289	CcSEcCtD
Pilocarpine—Shock—Doxorubicin—lung cancer	5.19e-05	0.000288	CcSEcCtD
Pilocarpine—Thrombocytopenia—Doxorubicin—lung cancer	5.17e-05	0.000286	CcSEcCtD
Pilocarpine—Tachycardia—Doxorubicin—lung cancer	5.15e-05	0.000285	CcSEcCtD
Pilocarpine—Hyperhidrosis—Doxorubicin—lung cancer	5.1e-05	0.000283	CcSEcCtD
Pilocarpine—Anorexia—Doxorubicin—lung cancer	5.03e-05	0.000279	CcSEcCtD
Pilocarpine—Nausea—Docetaxel—lung cancer	5.02e-05	0.000278	CcSEcCtD
Pilocarpine—Feeling abnormal—Methotrexate—lung cancer	5.02e-05	0.000278	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Methotrexate—lung cancer	4.98e-05	0.000276	CcSEcCtD
Pilocarpine—Hypotension—Doxorubicin—lung cancer	4.93e-05	0.000273	CcSEcCtD
Pilocarpine—Body temperature increased—Methotrexate—lung cancer	4.82e-05	0.000267	CcSEcCtD
Pilocarpine—Abdominal pain—Methotrexate—lung cancer	4.82e-05	0.000267	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.81e-05	0.000266	CcSEcCtD
Pilocarpine—Insomnia—Doxorubicin—lung cancer	4.77e-05	0.000264	CcSEcCtD
Pilocarpine—Paraesthesia—Doxorubicin—lung cancer	4.74e-05	0.000262	CcSEcCtD
Pilocarpine—Dyspnoea—Doxorubicin—lung cancer	4.71e-05	0.000261	CcSEcCtD
Pilocarpine—Somnolence—Doxorubicin—lung cancer	4.69e-05	0.00026	CcSEcCtD
Pilocarpine—Dyspepsia—Doxorubicin—lung cancer	4.65e-05	0.000257	CcSEcCtD
Pilocarpine—Decreased appetite—Doxorubicin—lung cancer	4.59e-05	0.000254	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Doxorubicin—lung cancer	4.56e-05	0.000252	CcSEcCtD
Pilocarpine—Pain—Doxorubicin—lung cancer	4.51e-05	0.00025	CcSEcCtD
Pilocarpine—Constipation—Doxorubicin—lung cancer	4.51e-05	0.00025	CcSEcCtD
Pilocarpine—Hypersensitivity—Methotrexate—lung cancer	4.49e-05	0.000249	CcSEcCtD
Pilocarpine—Asthenia—Methotrexate—lung cancer	4.37e-05	0.000242	CcSEcCtD
Pilocarpine—Feeling abnormal—Doxorubicin—lung cancer	4.35e-05	0.000241	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Doxorubicin—lung cancer	4.32e-05	0.000239	CcSEcCtD
Pilocarpine—Pruritus—Methotrexate—lung cancer	4.31e-05	0.000239	CcSEcCtD
Pilocarpine—Abdominal pain—Doxorubicin—lung cancer	4.17e-05	0.000231	CcSEcCtD
Pilocarpine—Body temperature increased—Doxorubicin—lung cancer	4.17e-05	0.000231	CcSEcCtD
Pilocarpine—Diarrhoea—Methotrexate—lung cancer	4.17e-05	0.000231	CcSEcCtD
Pilocarpine—Dizziness—Methotrexate—lung cancer	4.03e-05	0.000223	CcSEcCtD
Pilocarpine—Hypersensitivity—Doxorubicin—lung cancer	3.89e-05	0.000215	CcSEcCtD
Pilocarpine—Vomiting—Methotrexate—lung cancer	3.88e-05	0.000215	CcSEcCtD
Pilocarpine—Rash—Methotrexate—lung cancer	3.84e-05	0.000213	CcSEcCtD
Pilocarpine—Dermatitis—Methotrexate—lung cancer	3.84e-05	0.000213	CcSEcCtD
Pilocarpine—Headache—Methotrexate—lung cancer	3.82e-05	0.000211	CcSEcCtD
Pilocarpine—Asthenia—Doxorubicin—lung cancer	3.79e-05	0.00021	CcSEcCtD
Pilocarpine—Pruritus—Doxorubicin—lung cancer	3.73e-05	0.000207	CcSEcCtD
Pilocarpine—Nausea—Methotrexate—lung cancer	3.62e-05	0.0002	CcSEcCtD
Pilocarpine—Diarrhoea—Doxorubicin—lung cancer	3.61e-05	0.0002	CcSEcCtD
Pilocarpine—Dizziness—Doxorubicin—lung cancer	3.49e-05	0.000193	CcSEcCtD
Pilocarpine—Vomiting—Doxorubicin—lung cancer	3.36e-05	0.000186	CcSEcCtD
Pilocarpine—Rash—Doxorubicin—lung cancer	3.33e-05	0.000184	CcSEcCtD
Pilocarpine—Dermatitis—Doxorubicin—lung cancer	3.32e-05	0.000184	CcSEcCtD
Pilocarpine—Headache—Doxorubicin—lung cancer	3.31e-05	0.000183	CcSEcCtD
Pilocarpine—Nausea—Doxorubicin—lung cancer	3.13e-05	0.000174	CcSEcCtD
Pilocarpine—CYP3A4—Metabolism—GSTA2—lung cancer	9.02e-06	0.000138	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—RAF1—lung cancer	8.99e-06	0.000138	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—RAF1—lung cancer	8.96e-06	0.000137	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—IL2—lung cancer	8.88e-06	0.000136	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—RAF1—lung cancer	8.88e-06	0.000136	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—IL2—lung cancer	8.85e-06	0.000136	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—APOA1—lung cancer	8.84e-06	0.000135	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—PIK3CB—lung cancer	8.78e-06	0.000134	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—IL2—lung cancer	8.76e-06	0.000134	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—PIK3CB—lung cancer	8.75e-06	0.000134	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTA1—lung cancer	8.7e-06	0.000133	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYP1A1—lung cancer	8.68e-06	0.000133	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—PIK3CB—lung cancer	8.67e-06	0.000133	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ERCC2—lung cancer	8.61e-06	0.000132	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CG—lung cancer	8.6e-06	0.000132	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ABCC3—lung cancer	8.6e-06	0.000132	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—CXCL8—lung cancer	8.44e-06	0.000129	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—CXCL8—lung cancer	8.41e-06	0.000129	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ERBB3—lung cancer	8.38e-06	0.000128	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ERBB3—lung cancer	8.36e-06	0.000128	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—AKR1C1—lung cancer	8.33e-06	0.000128	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—CXCL8—lung cancer	8.33e-06	0.000128	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ERBB3—lung cancer	8.27e-06	0.000127	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—POMC—lung cancer	8.19e-06	0.000125	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—UGT1A1—lung cancer	8.09e-06	0.000124	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CG—lung cancer	8.07e-06	0.000124	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL2—lung cancer	8.06e-06	0.000123	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL2—lung cancer	8.04e-06	0.000123	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TERT—lung cancer	8.03e-06	0.000123	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TERT—lung cancer	8.01e-06	0.000123	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CREBBP—lung cancer	7.98e-06	0.000122	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL2—lung cancer	7.96e-06	0.000122	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TERT—lung cancer	7.93e-06	0.000121	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FGFR1—lung cancer	7.8e-06	0.000119	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GNG11—lung cancer	7.8e-06	0.000119	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FGFR1—lung cancer	7.78e-06	0.000119	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FGFR1—lung cancer	7.7e-06	0.000118	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HIF1A—lung cancer	7.68e-06	0.000118	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—POMC—lung cancer	7.68e-06	0.000118	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HIF1A—lung cancer	7.66e-06	0.000117	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HIF1A—lung cancer	7.58e-06	0.000116	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CD—lung cancer	7.56e-06	0.000116	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CREBBP—lung cancer	7.48e-06	0.000115	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ALB—lung cancer	7.47e-06	0.000114	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—APOA1—lung cancer	7.45e-06	0.000114	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALDOA—lung cancer	7.42e-06	0.000114	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—APOA1—lung cancer	7.41e-06	0.000114	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—APOA1—lung cancer	7.39e-06	0.000113	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KDR—lung cancer	7.35e-06	0.000113	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KDR—lung cancer	7.32e-06	0.000112	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—APOA1—lung cancer	7.32e-06	0.000112	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KDR—lung cancer	7.25e-06	0.000111	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NCOA3—lung cancer	7.21e-06	0.00011	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CD—lung cancer	7.09e-06	0.000109	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ADCY1—lung cancer	7.01e-06	0.000107	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ABCG2—lung cancer	7.01e-06	0.000107	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ALB—lung cancer	7e-06	0.000107	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—HPGDS—lung cancer	6.88e-06	0.000105	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ENO2—lung cancer	6.88e-06	0.000105	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PPP2R1B—lung cancer	6.83e-06	0.000105	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CG—lung cancer	6.8e-06	0.000104	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CG—lung cancer	6.77e-06	0.000104	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—APC—lung cancer	6.77e-06	0.000104	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KIT—lung cancer	6.77e-06	0.000104	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—NRAS—lung cancer	6.77e-06	0.000104	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—APC—lung cancer	6.75e-06	0.000103	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CG—lung cancer	6.75e-06	0.000103	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KIT—lung cancer	6.75e-06	0.000103	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—NRAS—lung cancer	6.75e-06	0.000103	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EGF—lung cancer	6.69e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CG—lung cancer	6.68e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—APC—lung cancer	6.68e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KIT—lung cancer	6.68e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—NRAS—lung cancer	6.68e-06	0.000102	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTT1—lung cancer	6.67e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EGF—lung cancer	6.67e-06	0.000102	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EGF—lung cancer	6.6e-06	0.000101	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GCLC—lung cancer	6.59e-06	0.000101	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP2A6—lung cancer	6.59e-06	0.000101	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CB—lung cancer	6.59e-06	0.000101	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PTGS2—lung cancer	6.53e-06	0.0001	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—MAPK3—lung cancer	6.48e-06	9.93e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—POMC—lung cancer	6.47e-06	9.91e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—MAPK3—lung cancer	6.46e-06	9.89e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—POMC—lung cancer	6.44e-06	9.87e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—POMC—lung cancer	6.42e-06	9.83e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—MAPK3—lung cancer	6.4e-06	9.8e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—BRAF—lung cancer	6.36e-06	9.74e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—POMC—lung cancer	6.36e-06	9.74e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—BRAF—lung cancer	6.34e-06	9.71e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CREBBP—lung cancer	6.3e-06	9.65e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL6R—lung cancer	6.29e-06	9.62e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—BRAF—lung cancer	6.28e-06	9.62e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CREBBP—lung cancer	6.28e-06	9.61e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL6R—lung cancer	6.27e-06	9.59e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CREBBP—lung cancer	6.26e-06	9.58e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ENO1—lung cancer	6.25e-06	9.57e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL6R—lung cancer	6.2e-06	9.5e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CREBBP—lung cancer	6.19e-06	9.49e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CB—lung cancer	6.18e-06	9.47e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—EGFR—lung cancer	6.17e-06	9.44e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—EGFR—lung cancer	6.15e-06	9.41e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PTGS2—lung cancer	6.13e-06	9.38e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—EGFR—lung cancer	6.09e-06	9.32e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MAP2K1—lung cancer	5.99e-06	9.17e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CD—lung cancer	5.98e-06	9.15e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MAP2K1—lung cancer	5.97e-06	9.14e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CD—lung cancer	5.95e-06	9.11e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CD—lung cancer	5.93e-06	9.08e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MAP2K1—lung cancer	5.91e-06	9.05e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ALB—lung cancer	5.9e-06	9.03e-05	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—PIK3CA—lung cancer	5.89e-06	9.02e-05	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—PIK3CA—lung cancer	5.88e-06	9e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CD—lung cancer	5.87e-06	8.99e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—KRAS—lung cancer	5.83e-06	8.92e-05	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	5.82e-06	8.91e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—KRAS—lung cancer	5.81e-06	8.89e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—KRAS—lung cancer	5.75e-06	8.81e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PTEN—lung cancer	5.7e-06	8.72e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP2E1—lung cancer	5.61e-06	8.58e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NQO1—lung cancer	5.54e-06	8.49e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—EP300—lung cancer	5.43e-06	8.32e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—PIK3CA—lung cancer	5.35e-06	8.2e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PTEN—lung cancer	5.34e-06	8.18e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—PIK3CA—lung cancer	5.34e-06	8.17e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MDM2—lung cancer	5.33e-06	8.16e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MDM2—lung cancer	5.31e-06	8.14e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—RAF1—lung cancer	5.31e-06	8.13e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—RAF1—lung cancer	5.3e-06	8.11e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	5.28e-06	8.09e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MDM2—lung cancer	5.26e-06	8.06e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ERBB2—lung cancer	5.26e-06	8.05e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—RAF1—lung cancer	5.24e-06	8.03e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ERBB2—lung cancer	5.24e-06	8.02e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CB—lung cancer	5.21e-06	7.98e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ERBB2—lung cancer	5.19e-06	7.94e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CB—lung cancer	5.19e-06	7.94e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MTOR—lung cancer	5.19e-06	7.94e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MTOR—lung cancer	5.17e-06	7.92e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CB—lung cancer	5.17e-06	7.92e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PTGS2—lung cancer	5.16e-06	7.9e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CB—lung cancer	5.12e-06	7.84e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MTOR—lung cancer	5.12e-06	7.84e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—EP300—lung cancer	5.1e-06	7.8e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—STK11—lung cancer	5e-06	7.65e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CXCL8—lung cancer	4.98e-06	7.63e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CXCL8—lung cancer	4.97e-06	7.61e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—HRAS—lung cancer	4.95e-06	7.58e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—HRAS—lung cancer	4.94e-06	7.56e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CXCL8—lung cancer	4.92e-06	7.53e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—HRAS—lung cancer	4.89e-06	7.48e-05	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—AKT1—lung cancer	4.81e-06	7.37e-05	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—AKT1—lung cancer	4.8e-06	7.35e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CASP3—lung cancer	4.77e-06	7.3e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL2—lung cancer	4.76e-06	7.29e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CASP3—lung cancer	4.76e-06	7.28e-05	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—AKT1—lung cancer	4.75e-06	7.28e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL2—lung cancer	4.75e-06	7.27e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL6—lung cancer	4.74e-06	7.26e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL6—lung cancer	4.72e-06	7.23e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CASP3—lung cancer	4.71e-06	7.21e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL2—lung cancer	4.7e-06	7.2e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL6—lung cancer	4.68e-06	7.16e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CCND1—lung cancer	4.64e-06	7.11e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—JUN—lung cancer	4.63e-06	7.09e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CCND1—lung cancer	4.63e-06	7.09e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTP1—lung cancer	4.62e-06	7.08e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—JUN—lung cancer	4.62e-06	7.07e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CCND1—lung cancer	4.58e-06	7.02e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—JUN—lung cancer	4.57e-06	7e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MMP9—lung cancer	4.51e-06	6.9e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PTEN—lung cancer	4.5e-06	6.89e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CAT—lung cancer	4.5e-06	6.89e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MMP9—lung cancer	4.49e-06	6.88e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CDKN1A—lung cancer	4.49e-06	6.88e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PTEN—lung cancer	4.48e-06	6.86e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CDKN1A—lung cancer	4.48e-06	6.86e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PTEN—lung cancer	4.47e-06	6.84e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MMP9—lung cancer	4.45e-06	6.81e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CDKN1A—lung cancer	4.43e-06	6.79e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PTEN—lung cancer	4.42e-06	6.77e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ABCB1—lung cancer	4.38e-06	6.7e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—AKT1—lung cancer	4.37e-06	6.69e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—AKT1—lung cancer	4.36e-06	6.67e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—AKT1—lung cancer	4.32e-06	6.61e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—TYMS—lung cancer	4.3e-06	6.58e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—EP300—lung cancer	4.29e-06	6.57e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EP300—lung cancer	4.27e-06	6.54e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EP300—lung cancer	4.26e-06	6.52e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTM1—lung cancer	4.25e-06	6.5e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EP300—lung cancer	4.22e-06	6.46e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SRC—lung cancer	4.16e-06	6.36e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SRC—lung cancer	4.14e-06	6.34e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SRC—lung cancer	4.1e-06	6.28e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—VEGFA—lung cancer	4.05e-06	6.2e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—VEGFA—lung cancer	4.04e-06	6.18e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP1A1—lung cancer	4.03e-06	6.17e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CA—lung cancer	4.02e-06	6.15e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—STAT3—lung cancer	4.01e-06	6.14e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NRAS—lung cancer	4e-06	6.12e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—VEGFA—lung cancer	4e-06	6.12e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—STAT3—lung cancer	4e-06	6.12e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ERCC2—lung cancer	3.99e-06	6.12e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NRAS—lung cancer	3.99e-06	6.1e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—STAT3—lung cancer	3.96e-06	6.06e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NRAS—lung cancer	3.95e-06	6.04e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MAPK3—lung cancer	3.83e-06	5.86e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MAPK3—lung cancer	3.82e-06	5.84e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MAPK3—lung cancer	3.78e-06	5.79e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CA—lung cancer	3.77e-06	5.77e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MYC—lung cancer	3.72e-06	5.7e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MYC—lung cancer	3.71e-06	5.68e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MYC—lung cancer	3.68e-06	5.63e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EGFR—lung cancer	3.64e-06	5.58e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EGFR—lung cancer	3.63e-06	5.56e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EGFR—lung cancer	3.6e-06	5.51e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—APOA1—lung cancer	3.46e-06	5.29e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KRAS—lung cancer	3.44e-06	5.27e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KRAS—lung cancer	3.43e-06	5.25e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KRAS—lung cancer	3.4e-06	5.2e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—AKT1—lung cancer	3.28e-06	5.03e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CA—lung cancer	3.18e-06	4.86e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CA—lung cancer	3.16e-06	4.84e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CG—lung cancer	3.15e-06	4.83e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CA—lung cancer	3.15e-06	4.83e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CA—lung cancer	3.12e-06	4.78e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—AKT1—lung cancer	3.08e-06	4.71e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TP53—lung cancer	3.06e-06	4.68e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TP53—lung cancer	3.05e-06	4.67e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TP53—lung cancer	3.02e-06	4.62e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—POMC—lung cancer	3e-06	4.6e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HRAS—lung cancer	2.93e-06	4.48e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CREBBP—lung cancer	2.92e-06	4.48e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HRAS—lung cancer	2.92e-06	4.46e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HRAS—lung cancer	2.89e-06	4.42e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL6—lung cancer	2.8e-06	4.29e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL6—lung cancer	2.79e-06	4.27e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CD—lung cancer	2.77e-06	4.25e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL6—lung cancer	2.76e-06	4.23e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALB—lung cancer	2.74e-06	4.19e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—AKT1—lung cancer	2.59e-06	3.97e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—AKT1—lung cancer	2.58e-06	3.95e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—AKT1—lung cancer	2.57e-06	3.94e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—AKT1—lung cancer	2.55e-06	3.9e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CB—lung cancer	2.42e-06	3.7e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PTGS2—lung cancer	2.39e-06	3.67e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PTEN—lung cancer	2.09e-06	3.2e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—EP300—lung cancer	1.99e-06	3.05e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CA—lung cancer	1.47e-06	2.26e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—AKT1—lung cancer	1.2e-06	1.84e-05	CbGpPWpGaD
